Icon Singapore and SAM Holdings partner in driving proton therapy treatment

The agreement will be valid for an initial term of three years.

Icon SOC Pte. Ltd has entered a medical services agreement with the Singapore Institute of Advanced Medicine Holdings (SAM Holdings) to provide proton therapy treatment services to Icon’s patients.  

The agreement will be valid for an initial term of three years, which will commence on 1 July, to ensure a steady flow of patients in the long run.

Moreover, The collaboration was made through SAM Holdings’ subsidiary, Proton Therapy Pte. Ltd, to enhance the provision of comprehensive cancer care to ICON’s patient network.

“At Icon, the patient is at the heart of everything we do,” Serena Wee, CEO of Icon ASEAN and Hong Kong, said.

“This collaboration marks our commitment to provide new and novel treatment options for our patients, enhancing our current suite of best-in-class cancer treatments and technologies,” Wee added.